DYT1 dystonia, the most common inherited form of primary dystonia, is a neurodevelopmental disease caused by a dominant mutation in TOR1A. This mutation ("∆E") removes a single glutamic acid from the encoded protein, torsinA. The effects of this mutation, at the molecular and circuit level, and the reasons for its neurodevelopmental onset, remain incompletely understood. To uniquely address key questions of disease pathogenesis, we generated a conditional Tor1a knock-in allele that is converted from wild type to DYT1 mutant ("induced"
Introduction
Dystonia is a prolonged abnormal involuntary movement that typically causes twisting or abnormal postures. Current treatments are empiric and only partially effective, and our limited knowledge of disease pathogenesis and pathophysiology have slowed the development of targeted therapies. While dystonia often results from neuronal injury or disease in the context of additional neurological symptoms ("secondary" dystonia), several inherited forms cause isolated dystonia without associated neurological findings ("primary" dystonia). Studies of genetic forms of primary dystonia have advanced understanding of dystonia biology because of the experimental power of mouse genetics, and ability to link molecular defects, cellular and circuit dysfunction, and neurological phenotypes with abnormal behaviors.
The most common form of inherited primary dystonia, DYT1, is caused by an in-frame 3-bp deletion within exon 5 of the gene TOR1A (OMIM: 605204)(1). This mutation ("∆E") results in the loss of a single glutamic acid from the encoded protein torsinA. One effect of the ∆E mutation is to impair normal torsinA function. Germline homozygous knock-in mice (Tor1a ∆E/∆E ) phenocopy the lethality and nuclear envelope abnormalities of Tor1a null mice (2) .
These findings predict that selective hindbrain expression of the DYT1 genotype at endogenous levels would produce an overtly dystonic model, but the mouse genetic reagents necessary to test this prediction do not exist.
To address these molecular and circuit-level questions of disease pathogenesis, we generated a novel line of conditional DYT1 knock-in mice that allowed us to pursue a series of in vivo studies not possible with existing models (Table 1 ). These mice express wild type torsinA until "induction" by Cre recombination, which swaps out a floxed wild type Tor1a exon 5, and brings a previously silent downstream ∆E-containing exon 5 into frame. This mutant allowed us to pursue a gene dosage study in vivo to rigorously test for organismal GOF effects of ∆E-torsinA.
We hypothesized that if the ∆E mutation conferred meaningful GOF toxic effects, more severe or novel phenotypes would emerge as the number of ∆E-Tor1a knock-in alleles increased.
Conversely, increasing levels of a solely hypomorphic (LOF) torsinA molecule might, paradoxically, ameliorate ∆E-torsinA-mediated phenotypes. Analyses of the growth, behavioral and histopathological characteristics of these mice demonstrated that increased dosage of the ∆E-Tor1a allele suppressed ∆E-torsinA-mediated phenotypes, suggesting that the ∆E mutation exerts an exclusive LOF effect. These mice also enabled us to test the pathophysiological importance of expressing the DYT1 genotype selectively within hindbrain structures; against predictions of the "two hit" model (19) , these mice did not exhibit any overt twisting movements. Considered together, these in vivo studies advance knowledge of the molecular and circuit abnormalities underlying primary dystonia, and establish a unique genetic tool valuable for future studies of dystonia pathogenesis and pathophysiology.
Results

A unique line of conditional DYT1 knock-in mice recapitulates molecular and ultrastructural features of ∆E-torsinA
To establish a model enabling the expression of ∆E-torsinA at endogenous levels in an anatomical-and temporal-specific manner, we constructed a conditional Tor1a allele that is converted from a wild type to a DYT1 mutant allele when acted upon by Cre recombinase. In this "Swap allele (Tor1a Swap )," the final exon is flanked by LoxP sites, and is followed by a downstream copy of the same exon harboring the ∆E mutation (an in-frame GAG deletion that removes a single glutamic acid, E; Fig. 1A) . Importantly, the endogenous stop codon (TGA) located in the floxed exon 5 ensures that in the absence of Cre, Tor1a Swap/Swap mice ( Fig. 1E-F abnormally concentrates in a perinuclear pattern ( Fig. 1D-E) . Analysis of Nissl stained brains showed that at birth, brain structure was grossly normal, as reported for Tor1a ∆E/∆E mutants (Fig.   1F ). TorsinA null and germline Tor1a ∆E/∆E mice exhibit characteristic neuronal nuclear envelope abnormalities (NE buds) (2), which were also observed in Tor1a i-∆E/i-∆E neurons (Fig. 1G ).
Considered together, these data confirm that the genetic strategy functions as designed, and that 
Increased Tor1a i-∆E gene dosage rescues neurodegeneration
We reported previously that torsinA LOF causes neurodegeneration in distinct sensorimotor ) did not show a significant loss of DCN neurons, demonstrating a protective effect of increased Tor1a i-∆E gene dosage, as observed for weight gain (Fig. 2D ). These findings are consistent with the conclusion that the ∆E mutation creates a hypomorphic form of torsinA that does not exert toxic GOF effects.
Hindbrain-selective induction of the DYT1 genotype does not cause abnormal twisting movements
Generation of the Tor1a Swap allele also enabled us to test a model of circuit dysfunction proposed to explain the reduced penetrance characteristic of the DYT1 mutation. This model is based upon diffusion tensor imaging (DTI) studies of human DYT1 subjects (16, 23) and DYT1 knock-in mice (18) . DTI imaging of DYT1 subjects who manifest dystonia exhibit microstructural abnormalities primarily of cerebellothalamic projections, whereas unaffected DYT1 mutation carriers and asymptomatic DYT1 knock-in mice (Tor1a ∆E/+ ) (24) exhibit both cerebellothalamic and thalamocortical defects. These data suggest that dystonia-related signaling could originate in cerebellothalamic projections, and that the thalamocortical abnormality prevents such aberrant signaling from reaching forebrain output nuclei. 
Discussion
We sought to address fundamental questions regarding the effects of the ∆E mutation at the molecular and circuit level, and to assess the contribution of these effects to motor dysfunction.
We pursued these questions by developing a novel genetic strategy that enabled us to convert
Tor1a from a wild type to a DYT1 mutant allele in an anatomic-and temporal-specific manner.
Using this powerful approach, we pursued a unique series of studies to assess potential gain-and loss-of-function effects of the ∆E mutation. These studies demonstrate that the ∆E mutation impairs torsinA function, as all phenotypes observed are those tied to torsinA LOF (3). None of the phenotypes we assessed-survival, growth, motor function, and histopathology-were exacerbated by increased Tor1a i-∆E gene dosage (Table 2 ). Indeed, increased Tor1a i-∆E gene dosage suppressed the extent of neurodegeneration, which is consistent with a strictly LOF effect of the DYT1 mutation. We also utilized the anatomic-selective capability of our model to explore the prediction that hindbrain-specific expression of the DYT1 genotype (Tor1a i-∆E/+ ) at endogenous levels would cause overtly abnormal behavior, which was refuted by this study.
These experiments demonstrate the unique power of this conditional knock-in model to address essential questions of DYT1 pathogenesis at the molecular and circuit levels, and establish a platform for future studies of dystonia pathophysiology.
We are aware of only four other conditional knock-in models in the scientific literature (26) (27) (28) (29) .
This strategy avoids the pitfalls that accompany transgenic or viral-based methods that overexpress a non-physiological amount of protein. Several of these previous reports utilized an approach in which a multi-exon wild type "minigene" is inserted upstream of a knock-incontaining exon (26, 28, 29) . Without cre, the minigene (including stop codon) is transcribed.
Following Cre removal of this wild type minigene, the mutant knock-in exon (and downstream exons) is utilized. Skvorak and colleagues used an approach similar to ours, but they fused the final two exons (27) . In contrast, the location of the DYT1 mutation within the final Tor1a exon enabled us to avoid the use of a minigene, or fused exons, and leaves the endogenous gene entirely intact. The success of our approach is demonstrated by our use of the Tor1a Swap allele to recapitulate previously reported behavioral and histopathological phenotypes, and to conditionally induce the DYT1 mutant torsinA in an anatomically selective manner. Anatomicaland temporal-selective manipulation of endogenous levels of ∆E-torsinA will be valuable for future studies dissecting the cellular anatomy of primary dystonia and assessing the role of neural development in disease pathogenesis, both of which are poorly understood.
DYT1 dystonia is dominantly inherited, but mouse models that mimic the human genotype fail to recapitulate a manifesting state (Table 1 ) (24) . The reasons for the absence of an overt phenotype in heterozygous mice (Tor1a ∆E/+ ) are unclear, but may include differences in the developmental timing or levels of torsinA-pathway molecules such as torsinB, LAP1 or LULL1.
The conditional knock-in model enabled us to generate the first homozygous ∆E-Tor1a model that is viable, which displays overtly abnormal motor behavior and dystonia-like movements.
The fact that this model recapitulates the behavioral and histological phenotypes identified using independent genetic strategies to manipulate Tor1a (3), further strengthens those findings and the link between developmental neurodegeneration of discrete sensorimotor regions and abnormal twisting movements (Table 1 ). In contrast to that report, we observe significant lethality prior to weaning using this conditional knock-in strategy. This difference may reflect the fact that in the approach used by Liang and colleagues the Tor1a ∆E allele is expressed constitutively, allowing compensatory mechanisms to develop prior to the postnatal vulnerable period (3).
To date, few studies have probed the mechanism of action of the ∆E mutation in vivo.
Comparisons between different versions of ∆E knock-in and Tor1a knockout mice demonstrate that the ∆E mutation impairs torsinA function and link torsinA hypofunction to abnormal twisting movements (Table 1 and 2) (2, 3, 30) . These studies do not exclude the possibility that the ∆E mutation also exerts neomorphic toxic GOF effects (distinct from dominant negative effect, which result in LOF). We devised a novel strategy that enabled us to obtain the first viable homozygous ∆E-Tor1a model, and exploited this model to directly investigate toxic GOF effects. We found no evidence for a toxic GOF effect in comparisons of mice harboring one
Swap/FLX ) or two (Nestin Cre+ Tor1a Swap/Swap ) ∆E alleles in the CNS, including assessments of growth and viability, motor behavior, and histopathology (Table 2 ). In fact,
increasing Tor1a i-∆E gene dosage significantly attenuated some phenotypes (growth and neuronal cell number). These results are most consistent with a model in which ∆E exerts LOF effects exclusively, and that higher levels of the hypomorphic protein are beneficial because they boost the overall amount of torsinA activity. This finding has important implications for devising therapeutic approaches for DYT1 dystonia. Our findings do not address whether increasing levels of mutant torsinA would be beneficial in DYT1 subjects, wherein the presence of wild type protein, dominant negative effects of mutant torsinA would likely prove harmful.
The Tor1a Swap allele also allowed us to test a model of DYT1 circuit dysfunction based on DTI imaging data from human subjects and a mouse model (16, 18, 23 Taken together, our findings provide knowledge of the effects of the ∆E mutation at the molecular and circuit levels that will be important for future studies of disease pathogenesis and therapeutic development. We developed a novel line of Tor1a mutant mice that will enable a range of future studies into the mechanisms underlying the unique vulnerability of discrete cell types to torsinA LOF and the role of neural development in the manifestation of dystonia.
Materials and Methods
Animal Husbandry
Mice were housed in the University of Michigan animal care facilities on a 12 hour light/dark cycle. Food and water were provided ad libitum. Animal care was in accordance with the University Committee on Use and Care of Animals.
Mice
Novel conditional knock-in mice were generated in collaboration with the Gene Targeting and
Transgenic Facility at UCONN Health. A BAC clone RP337K9 (from Children's Hospital
Oakland Research Institute) was used with a recombineering-based method to insert the region of interest into plasmid pl253. This modified bluescript plasmid contains a negative selection marker for ES targeting. Multi-step PCR was used to create the mutated exon 5 (3 base pair deletion 'GAG') + 3' UTR. After sequencing verification, the correct product was cloned into the pI253-Tor1a vector downstream of the wild type exon 5 + 3' UTR. To establish the "gene targeted construct" (Fig. 1A) , a loxp site was inserted upstream of the wild type exon 5 and a frtneomycin-frt-loxp cassette was inserted downstream of the wild type exon 5 + 3' UTR and before the mutated exon 5 + 3' UTR. Electroporation of the gene targeted construct into a hybrid B6/129SVEV ES line followed by screens using long range PCR allowed for collection of positive clones to generate a chimera. To generate the clean "Swap allele" (Fig. 1A) , the chimera were bred to Flpe-expressing mice to remove neomycin through recombination of Frt sites.
Nestin Cre+ (003771), Hprt Cre+ (004302), and En1 Cre+ (007916) mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Germline DYT1 knock-in mice (Tor1a ∆E ) were used in this study to verify our new mouse model (2) . Mice used to conditionally delete Tor1a (Tor1a FLX ) were previously published by our lab (3).
Genotyping
Ear (Postnatal day 17 and older) and tail samples (Postnatal day 0) were digested in 50mM
NaOH for 15 minutes at 95˚C followed by neutralization with 1M Tris HCl (Sigma). Resulting Other than validation experiments described in Figure 1 , all animals used for this study were derived from the Swap allele after neomycin cassette deletion. Immun-Blot PVDF membrane (Bio-Rad, 1620177) was followed by blocking with 5% non-fat dry milk dissolved in PBS-T (0.01M Phosphate Buffered Saline, Sigma, P-3813; 0.1% Tween (Sigma, C5042) was performed on unstained sections that were mounted on slides followed by cover slipping as described. Imaging was performed on a Axioskop2 microscope (Carl Zeiss Microscopy, USA) and an Olympus digital camera (model DP70, USA).
Stereology
Stereological investigations were completed on both mutant genotypes (Nestin Cre+
Tor1a
Swap/Swap and Nestin Cre+ Tor1a
Swap/FLX ) and one littermate control (Nestin Cre+
Swap/+ ). Five animals were used per genotype. Animals were transcardially perfused as described above at two months of age. Prior to cryosectioning, the primary researcher was reblinded to animal genotype and remained blinded until all stereological counts were made.
Brains were sectioned coronally at 30 μm and Nissl stained. Stereo Investigator (MBF Bioscience Williston, VT, USA) software was used to perform stereological analysis of neurons within the lateral, interposed, and medial regions of the deep cerebellar nuclei. Every third section was counted using a counting frame of 80 μm 2 and sampling grid of 125 μm 2 . These parameters allowed for a coefficient of Gunderson < 0.1. Counts from individual regions were summed and averaged per genotype to allow for comparison of total deep cerebellar nuclei.
Ultrastructural Analysis
Postnatal day 0 pups were transcardially perfused with 4% paraformaldehyde/2.5% glutaraldehyde (Electron Microscopy Sciences, 15710 and 16220 respectively) in PB. Brains were collected and post-fixed for 2 weeks in the same solution. Preparation of brains for electron microscopy was performed in collaboration with the Robert P. Apkarian Integrated Electron
Microscopy Core at Emory University as previously described (32) . Imaging was performed at University of Michigan's Microscopy and Image Analysis Laboratory using a Philips CM-100 transmission electron microscope (Philips, Amsterdam, Netherlands).
Animal Viability and Growth
To assess perinatal lethality in our Hprt Cre recombinase induced knock-in Tor1a i-∆E mouse model, we generated homozygous mice (Tor1a i-∆E/i-∆E ) by intercrossing two mice heterozygous for the germline mutation. Litters were genotyped at postnatal day 0 and monitored for lethality. . Breeding cages housing two females and one male were used to generate this cohort, and one week prior to giving birth, each female was separated into her own cage. This arrangement allowed for accurate data collection, prevented overcrowding, and reduced competition for nutrients. To measure survival and growth, each pup was weighed and genotyped at postnatal day 0 (birth weight). Date of birth was determined to be the day in which pups were observed between 6:00AM -12:00PM. Pups included in this study were weighed every other day until 21 days old, and then mice were weighed weekly until postnatal day 56.
Litters were observed each day in order to collect dead animals for survival analysis.
Motor Behavior
Mixed housing was used for all mice in this study to eliminate environmental bias. Male and female mice were used for analysis of survival, growth, tail suspension and grid hang behavior tests. Only males were used for balance beam behavior tests.
Tail suspension
Individual mice were held by the tail 20 cm above a to generate an overall severity score.
Horizontal Grid Hang
The horizontal grid apparatus was modeled after a previously published grid hang test (22) . The 
